FY22- Season Vaccines

The District of Columbia has issued a state and local contract opportunity for FY22 Season Vaccines, with a procurement timeline that spans a critically short window between April 27, 2022, and April 28, 2022. This procurement appears to be seeking seasonal vaccine supplies, likely for public health immunization programs across District government agencies. The contract opportunity suggests an urgent procurement process with an extremely compressed timeline for vendor responses, indicating a potentially time-sensitive public health requirement. While specific evaluation criteria are not explicitly detailed in the provided information, vaccine procurements typically require vendors to demonstrate comprehensive vaccine inventory, adherence to CDC and FDA guidelines, proper storage and transportation capabilities, and demonstrated experience in large-scale vaccine distribution. The extremely narrow window between posting and due dates suggests an expedited procurement process that requires immediate vendor attention and rapid response capabilities.

Given the limited information provided, specific details about set-aside designations or vendor restrictions cannot be comprehensively determined. However, vaccine procurement contracts frequently involve preferences for local vendors, minority-owned businesses, or those with specialized public health distribution experience. Such procurements often have stringent qualification requirements including proper licensing, temperature-controlled logistics infrastructure, and demonstrated capability to meet large-scale immunization program needs. While no specific budget range is indicated in the available information, municipal vaccine procurements can range significantly, potentially from tens of thousands to several hundred thousand dollars depending on vaccine type and quantity. The contract appears focused on seasonal vaccines, which typically implies influenza or other annually administered immunizations for public health purposes. Vendors would likely need to demonstrate comprehensive supply chain management, regulatory compliance, and the ability to quickly mobilize vaccine resources to meet District of Columbia public health requirements.